Last reviewed · How we verify

NCT07473050

Virtual Reality-Based 'Health at My Feet' Program for Individuals With Type 2 Diabetes

Not yet recruiting NA Last updated 16 March 2026
What this trial tests

NA trial testing "Health for My Feet" virtual reality program. in Diabetic Foot - Telemedical Monitoring in 70 participants. Not yet recruiting.

Timeline
16 April 2026
Primary endpoint
30 May 2026
30 July 2026

Quick facts

Lead sponsorEge University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment70
Start date16 April 2026
Primary completion30 May 2026
Estimated completion30 July 2026

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

19 and older, any sex, with Diabetic Foot - Telemedical Monitoring or Diabetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled experimental study aims to develop and evaluate the effectiveness of a Virtual Reality-Based "Health to My Foot" program designed for individuals with Type II Diabetes Mellitus. The study will assess the program's impact on diabetic foot knowledge, foot care self-efficacy, foot care behaviors, and foot health outcomes. The research will be conducted between April and October 2026 at a university hospital diabetes outpatient clinic in İzmir, Türkiye. A total of 70 participants diagnosed with Type II DM will be enrolled and randomly assigned to either the intervention group (n=35) or the control group (n=35) using stratified block randomization. Participants in the intervention group will receive the Virtual Reality-Based "Health to My Foot" program through virtual reality goggles and will have access to a recorded foot care training video for home use. They will also receive weekly motivational reminder messages for three months. The control group will receive standard outpatient care only. Data will be collected at baseline (pre-test), 1 month (post-test), and 3 months (follow-up) using validated scales and a nurse follow-up form to evaluate knowledge, self-efficacy, behaviors, and clinical foot health indicators. The findings are expected to contribute to sustainable patient education strategies and to support the prevention of diabetic foot complications and reduction of healthcare costs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07473050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing